Literature DB >> 9138601

Breast cancer stage at diagnosis: Caucasians versus Hispanics.

A J Zaloznik1.   

Abstract

In the Department of Defense health care system, all women have the same ability to access health care. Thus, there should be no racial differences in stage at diagnosis solely based on ability to seek health care. A retrospective review of breast cancer cases from 1980-1992 was conducted to determine if there were any differences in stage at diagnosis between Caucasian and Hispanic females. Data was available for 6134 Caucasian and 182 Hispanic females. Although not statistically significant, Hispanic females had fewer Stage I (41% versus 53%) and more Stage IIA (37% versus 28%) breast cancers than Caucasian females. Hispanic females had statistically fewer tumors < or = 1 cm (p < 0.001). Caucasian females were older (median age 58 years) at presentation than Hispanic females (median age 51 years). Significantly (p = 0.002) more Hispanic females (44%) were < 50 years old compared to Caucasian females (28%). When access to care is not an issue, Hispanic females tended to present at a more advanced stage although this did not reach statistical significance. Hispanic females with breast cancer were significantly younger than Caucasian females.

Entities:  

Mesh:

Year:  1997        PMID: 9138601     DOI: 10.1023/a:1005760719089

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  10 in total

1.  Cervical cancer among Hispanic women: assessing the impact on farmworkers.

Authors:  Faith Boucher; Marc B Schenker
Journal:  J Immigr Health       Date:  2002-07

Review 2.  Breast cancer in Latinas: gene expression, differential response to treatments, and differential toxicities in Latinas compared with other population groups.

Authors:  Tejal A Patel; Gerardo Colon-Otero; Celyne Bueno Hume; John A Copland; Edith A Perez
Journal:  Oncologist       Date:  2010-04-28

3.  Policy implications of early onset breast cancer among Mexican-origin women.

Authors:  Patricia Y Miranda; Anna V Wilkinson; Carol J Etzel; Renke Zhou; Lovell A Jones; Patricia Thompson; Melissa L Bondy
Journal:  Cancer       Date:  2011-01-15       Impact factor: 6.860

4.  Evaluation and outcomes of women with a breast lump and a normal mammogram result.

Authors:  Jennifer S Haas; Celia P Kaplan; Phyllis Brawarsky; Karla Kerlikowske
Journal:  J Gen Intern Med       Date:  2005-08       Impact factor: 5.128

5.  Breast cancer size and stage in Hispanic American women, by birthplace: 1992-1995.

Authors:  A N Hedeen; E White
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

6.  If we build it ... will they come?--establishing a cancer genetics services clinic for an underserved predominantly Latina cohort.

Authors:  Charité Ricker; Veronica Lagos; Nancy Feldman; Susan Hiyama; Sue Fuentes; Visanth Kumar; Kelly Gonzalez; Melanie Palomares; Kathleen Blazer; Katrina Lowstuter; Deborah MacDonald; Jeffrey Weitzel
Journal:  J Genet Couns       Date:  2006-12       Impact factor: 2.537

7.  Effectiveness of Cultivando la Salud: a breast and cervical cancer screening promotion program for low-income Hispanic women.

Authors:  María E Fernández; Alicia Gonzales; Guillermo Tortolero-Luna; Janet Williams; Monica Saavedra-Embesi; Wenyaw Chan; Sally W Vernon
Journal:  Am J Public Health       Date:  2009-03-19       Impact factor: 9.308

8.  Breast cancer treatment and ethnicity in British Columbia, Canada.

Authors:  Parvin Yavari; Maria Cristina Barroetavena; T Greg Hislop; Chris D Bajdik
Journal:  BMC Cancer       Date:  2010-04-21       Impact factor: 4.430

9.  Mammography screening and differences in stage of disease by race/ethnicity.

Authors:  Jillian Jacobellis; Gary Cutter
Journal:  Am J Public Health       Date:  2002-07       Impact factor: 9.308

10.  The effect of two church-based interventions on breast cancer screening rates among Medicaid-insured Latinas.

Authors:  Adrienne L Welsh; Angela Sauaia; Jillian Jacobellis; Sung-joon Min; Tim Byers
Journal:  Prev Chronic Dis       Date:  2005-09-15       Impact factor: 2.830

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.